Iselin, NJ, United States of America

Vipul B Amin

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of South Florida. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vipul B Amin. Retrieved from https://idiyas.com/inventor/vipul-b-amin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Vipul B Amin

Introduction

Vipul B Amin is a notable inventor based in Iselin, NJ (US). He has made significant contributions to the field of medical technology, particularly in the treatment of age-related macular degeneration. With a total of 2 patents, his work is paving the way for advancements in drug compositions.

Latest Patents

Amin's latest patents focus on nanoparticles and nanogel drug compositions specifically designed for the treatment of age-related macular degeneration. These innovations disclose the use of nanoparticles and nanogel drug compositions, which hold promise for improving treatment outcomes for patients suffering from this condition.

Career Highlights

Vipul B Amin is affiliated with the University of South Florida, where he continues to engage in research and development. His work is characterized by a commitment to enhancing therapeutic options through innovative drug delivery systems.

Collaborations

Some of his notable coworkers include Vijaykumar Bhadabhai Sutariya and Priyanka Sureshbhai Bhatt. Their collaborative efforts contribute to the advancement of research in the field of nanotechnology and drug development.

Conclusion

Vipul B Amin's contributions to the field of medical technology through his patents and collaborations highlight the importance of innovation in addressing health challenges. His work continues to inspire advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…